EVEX: financial statements from SEC

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Research and development	59M	45M	46M	45M	32M	36M
Selling, general and administrative	7M	7M	8M	8M	8M	5M
Operating expenses	66M	52M	54M	53M	41M	42M
Operating income	−66M	−52M	−54M	−53M	−41M	−42M
Interest expense	5M	3M	2M	2M	835,000	613,000
Pre-tax income	−69M	−46M	−64M	−49M	−35M	−36M
Income tax	95,000	1M	435,000	−558,000	427,000	395,000
Net income	−69M	−47M	−65M	−49M	−36M	−36M
Earnings per share	—	−0.14	−0.21	−0.16	−0.12	−0.13
Earnings per share, diluted	—	−0.14	−0.21	−0.16	−0.12	−0.13
Weighted average shares	—	326M	304M	304M	298M	276M
Weighted average shares, diluted	—	326M	304M	304M	298M	276M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	121M	103M	66M	42M	60M	56M	25M	28M
Short-term investments	312M	281M	344M	201M	228M	247M	255M	93M
Current assets	457M	411M	425M	250M	298M	313M	286M	210M
Property, plant and equipment	12M	15M	9M	5M	956,000	611,000	510,000	1M
Total assets	484M	435M	440M	261M	304M	318M	290M	215M
Current liabilities	120M	125M	81M	90M	83M	59M	55M	54M
Short-term debt	3M	3M	794,000	543,000	129,000	0	—	—
Long-term debt	296M	176M	167M	154M	142M	132M	68M	53M
Total liabilities	428M	311M	256M	248M	228M	194M	126M	109M
Equity	56M	124M	184M	13M	76M	124M	164M	105M

Metric	31/03/2026	31/03/2025
Operating cash flow	−68M	−25M
Depreciation and amortisation	394,000	82,000
Share-based compensation	1M	1M
Capital expenditure	526,000	464,000
Investing cash flow	−32M	19M
Financing cash flow	117M	9M